With over 20 years experience, we at Worldwide Clinical Trials take pride in consistently delivering among the best medical, scientific and operational expertise in chronic inflammatory disorders.
Science
Our team brings experience to your study that includes having lead the development and launch of chronic inflammatory therapies currently available on the market. Additionally, our long-standing and extensive ties with global key opinion leaders, investigators and researchers (in rheumatology, gastroenterology and dermatology) facilitates fast, informed decision making and captured opportunities.
Service
Our operational infrastructure for chronic inflammatory studies has been refined over time so that you benefit from:
- Experienced investigative sites with extensive referral patterns for chronic inflammatory indications, permitting efficient start-up and execution of your study.
- Our track record of consistent enrolment; meeting or undercutting timelines with patient quality verified by successful audits.
- Pro-active management of regulatory expectations for minimum disruption to timelines.
- A Worldwide Clinical Trials team of over 70% physicians facilitating effective site communication and in turn, excellent compliance and data quality.
Solutions
We understand the challenges of developing chronic inflammatory therapies, effective for both reducing inflammation and structural deterioration. Our experience spans the clinical research spectrum from small molecules through biologics, and exploratory programs to peri-approval studies demonstrating cost effectiveness and includes the following indications:
- Rheumatoid Arthritis
- Juvenile Arthritis
- Ankylosing Spondylitis
- Systemic Lupus Erythematosus and Lupus Nephritis
- Osteoarthritis
- Psoriatic Arthritis
- Psoriasis
- Crohn’s Disease
- Ulcerative Colitis